Naomi B Haas (Naomi Balzer-Haas)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Metastatic Renal Cell Carcinoma

Transcription Factor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature medicine

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Pedro C Barata, Catherine M Tangen, Melissa Plets, Ian M Thompson, Vivek Narayan, Daniel J George, Daniel Y C Heng, Brian M Shuch, Mark N Stein, Shuchi Gulati, Maria Tretiakova, Abhishek Tripathi, Georg Arnold Bjarnason, Peter Humphrey, Adebowale Adeniran, Ulka N Vaishampayan, Ajjai Alva, Tian Zhang, Scott Cole, Primo N Lara, Seth P Lerner, Naomi B Haas, Sumanta Kumar Pal
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
In-Young Jung, Robert L Bartoszek, Andrew J Rech, Sierra M Collins, Soon-Keat Ooi, Erik F Williams, Caitlin R Hopkins, Vivek Narayan, Naomi B Haas, Noelle V Frey, Elizabeth O Hexner, Donald L Siegel, Gabriela Plesa, David L Porter, Vito Adrian Cantu, John K Everett, Sonia Guedan, Shelley L Berger, Frederic D Bushman, Friederike Herbst, Joseph A Fraietta
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T cell-intrinsic Dysfunction. Cancer discovery (2023)
Catherine C Fahey, Jeffrey W Shevach, Ronan Flippot, Laurence Albiges, Naomi B Haas, Kathryn E Beckermann
Triplet Strategies in Metastatic Clear Cell Renal Cell Carcinoma: A Worthy Option in the First-Line Setting? American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43 (2023)
Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, Simon F Lacey, Andrew J Rech, Megan M Davis, Wei-Ting Hwang, Priti Lal, Erica L Carpenter, Shannon L Maude, Gabriela Plesa, Neha Vapiwala, Anne Chew, Michael Moniak, Ronnie A Sebro, Michael D Farwell, Amy Marshall, Joan Gilmore, Lester Lledo, Karen Dengel, Sarah E Church, Tyler D Hether, Jun Xu, Mercy Gohil, Thomas H Buckingham, Stephanie S Yee, Vanessa E Gonzalez, Irina Kulikovskaya, Fang Chen, Lifeng Tian, Kyle Tien, Whitney Gladney, Christopher L Nobles, Hayley E Raymond, null null, Elizabeth O Hexner, Donald L Siegel, Frederic D Bushman, Carl H June, Joseph A Fraietta, Naomi B Haas
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 28 (4) (2022)
Michael B Atkins, Opeyemi A Jagede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Mark N Stein, Jeffrey A Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael E Hurwitz, David J Peace, Sabina Signoretti, Thomas Denize, Alessia Cimadamore, Catherine J Wu, David A Braun, David J Einstein, Paul J Catalano, Hans Hammers
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, Richard J Lee, Melinda L Telli, Alice C Fan, Angela M DeMichele, Naomi B Haas, Manish R Patel, James J Harding, Martin H Voss, Taofeek Kunle Owonikoko, Bradley Carthon, Ramaprasad Srinivasan, Johanna C Bendell, Yonchu Jenkins, Sam H Whiting, Keith Orford, Mark K Bennett, Todd M Bauer
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Toni K Choueiri, Laurence Albiges, Michael B Atkins, Ziad Bakouny, Gennady Bratslavsky, David A Braun, Naomi B Haas, John B A G Haanen, A Ari Hakimi, Michael A S Jewett, Eric Jonasch, William G Kaelin, Payal Kapur, Chris Labaki, Bryan Lewis, David F McDermott, Sumanta K Pal, Kevin Pels, Susan Poteat, Thomas Powles, W Kimryn Rathmell, Brian I Rini, Sabina Signoretti, Nizar M Tannir, Robert G Uzzo, Hans J Hammers
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
Mark N Stein, Lawrence Fong, Ronald Tutrone, Anthony Mega, Elaine T Lam, Megan Parsi, Surya Vangala, Andres A Gutierrez, Naomi B Haas
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study. The oncologist 27 (6) (2022)
In-Young Jung, Vivek Narayan, Sierra M Collins, Andrew J Rech, Robert Bartoszek, Gwanui Hong, Megan M Davis, Jun Xu, Alina C Boesteanu, Julie S Barber-Rotenberg, Gabriela Plesa, Simon F Lacey, Julie K Jadlowsky, Donald L Siegel, Dana M Hammill, Park F Cho-Park, Shelley L Berger, Naomi B Haas, Joseph A Fraietta
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion. Science translational medicine 14 (670) (2022)